Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression

CM Miner, EB Brown, JS Gonzales… - Journal of Clinical …, 2002 - psychiatrist.com
Background: Major depressive disorder is frequently a chronic, recurrent condition
necessitating maintenance treatment. For some patients, compliance with daily …

The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder

ME Schmidt, M Fava, JM Robinson… - Journal of Clinical …, 2000 - psychiatrist.com
Background: A simple, once-weekly dosing regimen could be a convenient alternative for
many patients during long-term treatment of depression. Such a strategy might also be …

Citalopram treatment of fluoxetine nonresponders

ME Thase, JP Feighner, RB Lydiard - Journal of Clinical Psychiatry, 2001 - psychiatrist.com
Background: We assessed the tolerability and utility of switching fluoxetine nonresponders
to citalopram the day that fluoxetine therapy was stopped. Method: Fifty-eight outpatients …

Treatment Approaches to Major Depressive Disorder RelapsePart 1: Dose Increase

ME Schmidt, M Fava, S Zhang, J Gonzales… - Psychotherapy and …, 2002 - karger.com
Objective: Although continuing antidepressant treatment after patients have responded to
medication has been shown to greatly reduce the risk of relapse, this risk is not eliminated. A …

Patient compliance to a new enteric-coated weekly formulation of fluoxetine during continuation treatment of major depressive disorder

A Claxton, E de Klerk, M Parry… - Journal of Clinical …, 2000 - psychiatrist.com
Background: A new formulation of entericcoated fluoxetine given once weekly could be a
useful option for the long-term treatment of depression, but compliance to once-weekly …

Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline

ME Thase, SL Blomgren, MA Birkett… - Journal of Clinical …, 1997 - psychiatrist.com
Background: This study was conducted to determine if patients with major depressive
disorder who had previously failed treatment with one serotonin selective reuptake inhibitor …

Patient compliance with enteric-coated weekly fluoxetine during continuation treatment of major depressive disorder

MD Erik de Klerk - J Clin Psychiatry, 2001 - psychiatrist.com
Background: A once-weekly enteric-coated formulation of fluoxetine represents a new,
effective option for the long-term treatment of clinically diagnosed depression. This study …

Citalopram treatment of fluoxetine-intolerant depressed patients

JR Calabrese, PD Londborg, MD Shelton… - Journal of Clinical …, 2003 - psychiatrist.com
Background: We assessed the tolerability of and response to citalopram in depressed
patients who had discontinued fluoxetine treatment due to adverse events. Method: Fifty-five …

Exploring treatment alternatives: weekly dosing of fluoxetine for the continuation phase of major depressive disorder

WJ Burke, DA McArthur-Miller - Journal of Clinical Psychiatry, 2001 - psychiatrist.com
Antidepressant medications are typically taken on a daily basis owing to both tradition and
the pharmacokinetics of these agents. Because fluoxetine and its primary metabolite …

Efficacy and safety of weekly treatment with enteric-coated fluoxetine in patients with major depressive disorder

TG Dinan - Journal of Clinical Psychiatry, 2001 - psychiatrist.com
Efficacy and Safety of Weekly Treatment With Enteric-Coated Fluoxetine in Patients With
Major Depressive Disorder Page 1 © Copyright 2001 Physicians Postgraduate Press, Inc …